Pi Therapeutics, a preclinical-stage pharmaceutical company focused on treating cancer, has secured $19.7 million in Series B financing. Pontifax led the round.
Source: Press Release
Pi Therapeutics, a preclinical-stage pharmaceutical company focused on treating cancer, has secured $19.7 million in Series B financing. Pontifax led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination